12 Best Under-the-Radar Stocks to Buy According to Hedge Funds

6. TransMedics Group, Inc. (NASDAQ:TMDX)

TransMedics Group, Inc. (NASDAQ:TMDX) is one of the best under-the-radar stocks to buy according to hedge funds. On February 25, Baird raised its price target on TransMedics Group, Inc. (NASDAQ:TMDX) from $154 to $168 and kept its Outperform rating on the stock. Baird updated its model after the company reported fourth-quarter results that surpassed expectations and provided a 2026 outlook that was also above expectations.

On February 25, Oppenheimer also raised its price target on TransMedics Group, Inc. (NASDAQ:TMDX) from $150 to $175 and maintained an Outperform rating after the company’s quarterly results. Oppenheimer pointed out that the company continues to invest in strengthening its clinical position across heart and lung, while kidney is expected to become the next area of focus.

On the same day, Piper Sandler increased its price target on TransMedics Group, Inc. (NASDAQ:TMDX) from $140 to $160 and maintained its Overweight rating on the stock. The firm said that the company reported Q4 results that exceeded its key financial targets.

Piper Sandler noted that the company’s guidance for the year looked solid, particularly for revenue, where it believes there could still be potential upside.

TransMedics Group, Inc. (NASDAQ:TMDX) is a medical technology company that specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. The company has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.